Brokerages Set BrightSpring Health Services, Inc. (NASDAQ:BTSG) Target Price at $23.56

BrightSpring Health Services, Inc. (NASDAQ:BTSG - Get Free Report) has been given an average recommendation of "Moderate Buy" by the ten analysts that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $23.56.

Several research analysts have recently weighed in on BTSG shares. Mizuho set a $26.00 price objective on BrightSpring Health Services in a research report on Monday, May 5th. Wells Fargo & Company lifted their target price on BrightSpring Health Services from $25.00 to $27.00 and gave the stock an "overweight" rating in a report on Tuesday, May 13th. Finally, Morgan Stanley boosted their price target on BrightSpring Health Services from $20.00 to $25.00 and gave the company an "overweight" rating in a research note on Friday, May 9th.

BrightSpring Health Services Trading Down 1.3%

BrightSpring Health Services stock traded down $0.29 during mid-day trading on Monday, hitting $21.60. 6,805,994 shares of the stock were exchanged, compared to its average volume of 1,519,019. The stock has a market capitalization of $3.76 billion, a price-to-earnings ratio of -83.08 and a beta of 2.58. BrightSpring Health Services has a 12 month low of $10.15 and a 12 month high of $25.57. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63. The firm's fifty day simple moving average is $20.56 and its two-hundred day simple moving average is $19.60.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last announced its earnings results on Friday, May 2nd. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.10. The business had revenue of $2.88 billion during the quarter, compared to the consensus estimate of $2.74 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. BrightSpring Health Services's quarterly revenue was up 25.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.12 earnings per share. Analysts forecast that BrightSpring Health Services will post 0.59 EPS for the current year.

Institutional Trading of BrightSpring Health Services

Hedge funds and other institutional investors have recently bought and sold shares of the business. FMR LLC lifted its stake in shares of BrightSpring Health Services by 21.6% in the fourth quarter. FMR LLC now owns 22,102,490 shares of the company's stock valued at $376,405,000 after buying an additional 3,933,303 shares in the last quarter. Vanguard Group Inc. lifted its position in BrightSpring Health Services by 24.6% in the 1st quarter. Vanguard Group Inc. now owns 6,633,744 shares of the company's stock valued at $120,004,000 after acquiring an additional 1,308,651 shares in the last quarter. Invesco Ltd. boosted its stake in BrightSpring Health Services by 41.0% during the 1st quarter. Invesco Ltd. now owns 6,172,597 shares of the company's stock valued at $111,662,000 after purchasing an additional 1,794,035 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in BrightSpring Health Services by 264.7% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 5,772,772 shares of the company's stock valued at $104,430,000 after purchasing an additional 4,189,805 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in BrightSpring Health Services by 13.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,698,629 shares of the company's stock worth $45,959,000 after purchasing an additional 328,977 shares in the last quarter.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.